The Champalimaud Clinical Centre is a state-of-the-art medical facility for management of oncologic, neuropsychiatric and related diseases. Its core mission is the provision of premier patient management supported by programmes of translational research.
In carrying out its mission the Champalimaud Clinical Centre is committed to:
- Having the patient as the core focus of its clinical activity by means of offering personalised care which promotes quality of life;
- Implementing standards of excellence in patient care, employing diagnosis and management by multidisciplinary Disease Management Teams, ensuring that state-of-the-art knowledge is utilized to optimize clinical outcome and minimise patient risk;
- Giving our patients the opportunity to participate in innovative diagnostic and treatment programmes which stem from scientific breakthroughs in the different areas of oncology and neuropsychiatry;
- Developing advanced training programmes in oncology and creating educational and doctoral programmes to support and nourish our clinical activities.
Cancer care at the CCC is organised into seven Disease Management Teams (DMTs) comprising, among others, medical oncologists, radiation oncologists, anaesthetists, surgeons, nuclear medicine specialists, pathologists, nurses, imaging specialists, nutritionists and psycho-oncologists – which meet regularly to determine the most effective management of each individual patient. Our DMTs currently cover the most frequent types of cancer including lung, breast, skin, gynaecological cancers, prostate, stomach, colon and bladder cancers, myelomas and lymphomas.
The CCC operates programmes which are common to all the multidisciplinary teams. In particular:
- Risk Assessment and Early Diagnosis;
- Integrated treatment of oligometastatic Disease.
Through these programmes we aim to implement practices in the evaluation of oncologic risk as well diagnostic methods which aid early detection of both primary tumours and the phases of the metastatic process.
In neuropsychiatry our team of specialists focus on diseases in the Obsessive Compulsive Disorders (OCD) spectrum, developing programmes of scientific and clinical investigation based on actual cases occurring in the Centre.
Where possible, in both oncology and neuropsychiatry, the option of participating in research and/or clinical trials is made available to our patients. The CCC strives to be at the forefront of research, diagnosis and treatment of disease. In this way, the centre’s world-renowned faculty confronts disease at its root by bringing the latest technology and techniques to bear on the fight against oncologic and neuropsychiatric illnesses.